Related Experiment Videos
Prevention of experimental allergic encephalomyelitis by nonencephalitogenic basic peptides
Archives of Biochemistry and Biophysics
|May 1, 1973
Summary
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Antigen-stimulated rosette formation by T lymphocytes in experimental allergic encephalomyelitis.
Neurochemical research·2013
Immunity to T cell receptor peptides in multiple sclerosis. III. Preferential immunogenicity of complementarity-determining region 2 peptides from disease-associated T cell receptor BV genes.
Journal of immunology (Baltimore, Md. : 1950)·1998
Proton NMR study of peptides from myelin basic protein: evidence for Lys74-His77 interaction revealed from histidine line broadening.
Biochimica et biophysica acta·1996
T cell receptor peptides in treatment of autoimmune disease: rationale and potential.
Journal of neuroscience research·1996
METTL3/FOSL1-associated inflammatory and autophagy-related responses involve m6A-related regulation in sepsis-induced acute kidney injury.
Archives of biochemistry and biophysics·2026
Simultaneous induction of apoptosis and ferroptosis by a novel thiolato-bridged manganese(I)-based CO-releasing molecule in pancreatic and prostate cancer cells.
Archives of biochemistry and biophysics·2026
Taxamairin B inhibits inflammatory response by suppressing activation of PI3K/AKT/NF-kappaB signaling in a mouse model of transfusion-related acute lung injury.
Archives of biochemistry and biophysics·2026
Sodium lactate attenuates LPS-induced acute kidney injury by suppressing CHOP dependent endoplasmic reticulum stress.
Archives of biochemistry and biophysics·2026
β-Escin interactions with lipid membranes: Role of lipid composition and impact on SARS-CoV-2 E protein transmembrane domain localization.
Archives of biochemistry and biophysics·2026
Upadacitinib for refractory generalized lichen sclerosus: a case report and brief literature review.
Frontiers in immunology·2026
Case Report: A case report of bullous pemphigoid triggered by sintilimab (PD-1 inhibitor).
Frontiers in immunology·2026